Stock & Company Details
Aligos Therapeutics Inc $ALGS
Price:
N/A
N/A
6.2M
$7.8M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.17
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ALGS technical indicators
Latest Aligos Therapeutics Inc (ALGS) indicator readings as of 2026-11-19.
ALGS's 14-day RSI is 16.5, in oversold territory. ADX reads 40.6, indicating a trending market. MACD (12, 26, 9) is -1.02, below the zero line.
Overview
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
Finance Bot
Ask your questions
Start by typing a question below.